To predict the prognosis of melanoma patients, we calculated the risk score of each patient based on the expression and corresponding lambda value of seven genes (PLA2G2D, FUT8, PLA2G4E, PLA2G5, PLA2G1B, B3GNT2, and ST3GAL5). This evidence concerns the gene PLA2G2D and melanoma.